IP Library Patent Application 13194612
Patent Application
App. No. 13/194,612

SURGICAL DEVICE AND METHOD FOR PERFORMING COMBINATION REVASCULARIZATION AND THERAPEUTIC SUBSTANCE DELIVERY TO TISSUE

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
13/194,612
Abstract

A surgical device is provided for both ablating a channel in a patient's tissue and also delivering a therapeutic agent. The device includes an elongated multi-lumen tube, an elongated tissue ablating assembly, and a therapeutic agent delivery assembly. The therapeutic agent is capable of being delivered into the channel and/or to the surrounding tissue. The device may further include a second multi-lumen tube also capable of delivering therapeutic agents. A method is also provided for using such a surgical device to ablate a channel in a patient's tissue and also deliver a therapeutic agent to the tissue, for example, for transmyocardial revascularization or other procedures.

Claims (44)

1 . A method for ablating a channel and delivering a therapeutic agent into a desired region of tissue, comprising:

(a) providing a surgical device having an elongated multi-lumen tube with a proximal end in connection with a control handle assembly and extending to a distal treatment end adapted for ablating and delivering the therapeutic agent to the tissue, said multi-lumen tube having a tissue ablating assembly extending through a first lumen of the multi-lumen tube and a therapeutic agent delivery assembly incorporating a second lumen of the multi-lumen tube, wherein the ablating assembly has a proximal end in connection with a source of ablating energy and extending distally to an ablating tip and the therapeutic agent delivery assembly has a therapeutic agent receiving port at a proximal end and extends distally to an injection tip and wherein the ablating tip and injection, tip are disposed such that the therapeutic agent can be delivered into tissue surrounding a channel formed by the ablating tip;

(b) positioning the treatment end adjacent to the desired region of tissue;

(c) energizing the source of ablating energy such that the ablating tip is capable of ablating the tissue;

(d) advancing the ablating tip to form a channel in the tissue; and

(e) dispensing the therapeutic agent from the injection tip into the tissue adjacent the channel.

2 . The method of claim 1 , wherein the ablating energy is a laser and the ablating tip is a lasing tip.

3 . The method of claim 1 , further comprising dispensing the therapeutic agent into the channel.

4 . The method of claim 1 , wherein dispensing a therapeutic agent comprises dispensing the agent into multiple locations adjacent to the channel.

5 . The method of claim 1 , wherein the injection tip in the form of a needle.

6 . The method of claim 5 , wherein the device further comprises a second and third needle and the three needles are radially spaced so they enter the tissue surrounding and centered on the formed channel.

7 . The method of claim 6 , wherein each of the needles comprises a plurality of holes arrayed along the length of the needle.

8 . The method of claim 1 , wherein the region of tissue comprises myocardium.

9 . The method of claim 1 , wherein the therapeutic agent comprises stem cells.

10 . A method for performing a combination myocardial revascularization procedure and delivering a therapeutic agent to a desired region of heart tissue, comprising the steps of:

(a) providing a surgical device having an first elongated multi-lumen tube with a proximal end in connection with a control handle assembly and extending to a distal treatment end, said first multi-lumen tube having a tissue ablating assembly supported in a first lumen of the multi-lumen tube and a therapeutic agent delivery assembly supported in a second lumen of the multi-lumen tube, wherein the ablating assembly has a proximal end in connection with a source of ablating energy and extending distally to an ablating tip for creating a channel in the tissue and wherein the therapeutic agent delivery assembly has a proximal end that is connectable with a source of the therapeutic agent and extending distally to a delivery tip disposed proximally to the ablating tip such that the therapeutic agent can be delivered from the source and into the channel, said surgical device further comprising a second elongated multi-lumen tube connectable with a second therapeutic agent at a proximal end and extending to an injection tip and adapted for delivering the second therapeutic agent from the source to the injection tip for dispensing into the tissue;

(b) positioning the treatment end adjacent the desired region of tissue;

(c) energizing the source of ablating energy such that the ablating tip is capable of ablating the tissue;

(d) advancing the ablating tip into the tissue to form a channel in the tissue;

(e) advancing the injection tip into the desired region of tissue; and

(f) dispensing the therapeutic agent from the delivery tip into the channel.

11 . The method of claim 10 , wherein the step of advancing the ablating tip comprises advancing the first multi-lumen lumen tube relative to the second multi-lumen lumen tube.

12 . The method of claim 10 , wherein the step of advancing the ablating tip comprises advancing the ablating tip outwardly relative to the injection tip.

13 . The method of claim 10 , further including the step of extending the first multi-lumen lumen tube relative to the second multi-lumen lumen tube.

14 . The method of claim 10 , further comprising the step of dispensing a therapeutic agent from the agent injection tip into the desired region of tissue.

15 . The method of claim 10 , wherein the ablating energy is a laser and the ablating tip is a lasing tip.

16 . The method of claim 10 , wherein the step of dispensing the therapeutic agent comprises dispensing a first therapeutic agent through the first delivery tip and a second therapeutic agent through the injection tip.

17 . The method of claim 10 , wherein the injection tip is advanced into the desired region of tissue prior to advancing the ablating tip into the tissue to form the channel.

18 . The method of claim 10 , wherein the step of advancing the injection tip into the desired region of tissue and a step of injecting the second therapeutic agent into the desired region of tissue occur prior to the step of advancing the ablating tip into the tissue.

19 . The method of claim 10 , further comprising the step of dispensing a first therapeutic agent from the delivery tip into the channel and dispensing a second therapeutic agent from the injection assembly into the desired region of tissue.

20 . The method of claim 10 , wherein the step of dispensing a therapeutic agent further comprises dispensing the agent into the channel formed by the ablating tip and into tissue adjacent the channel.

21 . The method of claim 10 , further including the step of retracting the ablating tip from the tissue.

22 . A method for performing a combination myocardial revascularization procedure and delivering a therapeutic agent to a desired region of heart tissue, comprising:

positioning a surgical device having a proximal end with a control handle assembly and a distal end connected to a treatment assembly, such that the distal end of the treatment assembly is positioned adjacent to the desired region of heart tissue;

energizing a laser such that an ablating tip in the treatment assembly is capable of ablating the heart tissue;

advancing the ablating tip into the heart tissue and ablating tissue to form a channel in the heart tissue;

advancing a plurality of needles from the treatment assembly into the desired region of tissue; and

dispensing the therapeutic agent from a source in the surgical device through the plurality of needles directly into the heart tissue surrounding the channel.

23 . The method of claim 22 , wherein the plurality of needles are radially spaced so that they are advanced into the tissue surrounding and centered on the channel.

24 . The method of claim 22 , wherein each of the needles comprises a plurality of holes arrayed along the length of the needle.

25 . The method of claim 24 , wherein the tip of each of the needles is capped with a point.

26 . The method of claim 22 , wherein the plurality of needles is three needles.

27 . The method of claim 22 , wherein the therapeutic agent comprises stem cells.

28 . The method of claim 22 , wherein the advancement of the ablating tip and the needles into the heart tissue is a continuous operation accomplished by a single fully extended motion of an actuator located in the control handle assembly.

Assignments (7)
RELEASE OF SECURITY INTEREST IN PATENTS Recorded Dec 1, 2017
From: HEALTHCARE FINANCIAL SOLUTIONS, LLC, AS ADMINISTRATIVE AGENT
To: CRYOLIFE, INC.; CRYOLIFE ACQUISITION CORPORATION; CARDIOGENESIS CORPORATION (N/K/A CRYOLIFE, INC.); HEMOSPHERE, INC.; ON-X LIFE TECHNOLOGIES, INC. (F/K/A MCRI, INC.); VALVE SPECIAL PURPOSE CO., LLC
Reel/Frame 044621/0240 →
SECURITY INTEREST Recorded Jan 21, 2016
From: CRYOLIFE, INC., AS GRANTOR; VALVE SPECIAL PURPOSE CO., LLC, AS GRANTOR; ON-X LIFE TECHNOLOGIES, INC., AS GRANTOR
To: HEALTHCARE FINANCIAL SOLUTIONS, LLC, AS AGENT
Reel/Frame 037569/0212 →
ASSIGNMENT OF INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Nov 19, 2015
From: GENERAL ELECTRIC CAPITAL CORPORATION, AS RETIRING AGENT
To: HEALTHCARE FINANCIAL SOLUTIONS, LLC, AS SUCCESSOR AGENT
Reel/Frame 037146/0466 →
SECURITY INTEREST Recorded Feb 12, 2015
From: CRYOLIFE, INC.
To: GENERAL ELECTRIC CAPITAL CORPORATION, AS AGENT
Reel/Frame 034947/0248 →
MERGER Recorded Jan 15, 2015
From: CARDIOGENESIS CORPORATION
To: CRYOLIFE, INC.
Reel/Frame 034723/0249 →
SECURITY INTEREST Recorded Sep 29, 2014
From: CRYOLIFE, INC.; HEMOSPHERE, INC.; CARDIOGENESIS CORPORATION
To: GENERAL ELECTRIC CAPITAL CORPORATON, AS AGENT
Reel/Frame 033835/0742 →
SECURITY AGREEMENT Recorded Oct 31, 2011
From: CRYOLIFE, INC.
To: GENERAL ELECTRIC CAPITAL CORPORATION, AS AGENT
Reel/Frame 027146/0940 →